round table with prof. john gribben and prof. stephan stilgenbauer on cll
Published 8 years ago • 228 plays • Length 16:13Download video MP4
Download video MP3
Similar videos
-
1:31
frontline treatment for cll: the changing paradigm
-
2:23
john gribben talks on coronavirus
-
3:22
bcr inhibitors improving cll patient outcomes
-
1:38
what are the economics of treating cll?
-
2:43
resistance mechanisms of current treatments in cll
-
1:56
hematology: patient with low platelets part 1
-
14:57
ch6 | using z-scores to compute probabilities/proportions in normal distributions
-
6:32
attitude pratique devant une fa sous inhibiteur de btk
-
6:50
an overview of the immunotherapy landscape in aml: antibodies, bispecifics, & car-t
-
2:16
the role of covalent btkis in the management of cll
-
12:10
12th international workshop on non-hodgkin lymphoma (iwnhl) 2014: day 1 meeting highlights
-
1:34
australasian lymphoma alliance consensus practice statement on the diagnosis and management of fl
-
3:32
a polygenic risk score to determine a patient's predisposition to cll
-
3:01
the predictive value of stereotyped bcr subsets in cll
-
1:54
therapeutic approaches in the front-line for patients with ptcl
-
0:56
patient-reported outcomes explored in the beat aml trial
-
1:15
the diagnosis and management of mds/mpn with neutrophilia (atypical cml)
-
3:06
cll: the green study
-
2:25
using ctdna in lymphoma: recent advances and future directions
-
0:49
venice ii trial: health-related qol in patients with cll treated with venetoclax
-
3:27
the implementation of a data-driven cll-tim algorithm into an epic-based electronic health record
-
1:24
sequencing of btk inhibitors in cll